Cargando…

P19-07. Development of a protective HIV/SIV vaccine based on a self-boosting cytomegalovirus vector

Detalles Bibliográficos
Autores principales:	Ambagala, A, Willer, DO, Chan, J, Marsh, A, Sandstrom, P, Pilon, R, Fournier, J, MacDonald, KS
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767834/ http://dx.doi.org/10.1186/1742-4690-6-S3-P327

Ejemplares similares

Examining the Species-Specificity of Rhesus Macaque Cytomegalovirus (RhCMV) in Cynomolgus Macaques
por: Marsh, Angie K., et al.
Publicado: (2015)

A novel strain of cynomolgus macaque cytomegalovirus: implications for host-virus co-evolution
por: Russell, Justen N. Hoffman, et al.
Publicado: (2016)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
por: Kannanganat, S, et al.
Publicado: (2009)

P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
por: Yeh, WW, et al.
Publicado: (2009)

Late gene expression–deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV
por: Hansen, Scott G., et al.
Publicado: (2023)

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
por: Berkower, I, et al.
Publicado: (2012)

P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS
por: Beignon, A, et al.
Publicado: (2009)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
por: Hamimi, C, et al.
Publicado: (2012)

P12-07. Novel HIV vaccines using chimeric influenza HA vectors
por: Steinhauer, DA, et al.
Publicado: (2009)

P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
por: Felber, BK, et al.
Publicado: (2009)

Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
por: Banerjee, K, et al.
Publicado: (2012)

Lv4, an activity that restricts nuclear entry of SIV(MAC)/SIV(SM) in human blood cells
por: Pizzato, Massimo, et al.
Publicado: (2013)

P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
por: Valentin, A, et al.
Publicado: (2009)

The viral vector vaccine VSV-GP boosts immune response upon repeated applications
por: Tober, R, et al.
Publicado: (2012)

A conditionally replicating SIV variant that can be used to study the mechanism of protection conferred by live attenuated SIV vaccines
por: Das, Atze T, et al.
Publicado: (2011)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
por: Jensen, K, et al.
Publicado: (2012)

Evaluation of a replication-competent VSV-SIV vaccine candidate
por: Jurgens, CK, et al.
Publicado: (2012)

Acute infection by SIV: massive immunological damage
por: Roederer, Mario
Publicado: (2006)

Boosting Live Malaria Vaccine with Cytomegalovirus Vector Can Prolong Immunity through Innate and Adaptive Mechanisms
por: Gbedande, Komi, et al.
Publicado: (2023)

P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
por: Stambas, J, et al.
Publicado: (2009)

OA07-02. Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection
por: Benlahrech, A, et al.
Publicado: (2009)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
por: Boopathy, Archana V., et al.
Publicado: (2023)

CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts
por: Kato, Seiichi, et al.
Publicado: (2021)

Recombinant attenuated M.tuberculosis-SIVgag(rAMtb-gag) vaccination primes for SIV-specific CD8 T cell response that are boosted by Ad5-SIVgag in mice
por: Kadayam Ranganathan, U, et al.
Publicado: (2012)

Maturation of protective immunity induced by SIVΔnef correlates with differential expression of transcription factors in SIV-specific CD8+ T cells
por: Billingsley, JM, et al.
Publicado: (2012)

P07-07 Put the promotion of physical activity for people with non-communicable diseases on the political agenda in Luxembourg!
por: Lion, Alexis, et al.
Publicado: (2022)

Tetherin antagonism by HIV-1 and its SIV precursors
por: Kirchhoff, Frank
Publicado: (2011)

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge
por: Shang, L, et al.
Publicado: (2012)

SIVconsv DNA prime - TLR7/IFNα adjuvanted long peptide boost induces potent CD4+ Ab responses and protects against high dose intrarectal SIV challenge
por: Koopman, G, et al.
Publicado: (2012)

Structure-guided modification and optimization of antibody VRC07
por: Kwon, Y, et al.
Publicado: (2012)

P07-07. Non-progressive paediatric HIV infection is associated with virus attenuation and increase in CD8+ specific T cell responses over time
por: Prado, JG, et al.
Publicado: (2009)

P16-51. Functional characterization of novel SIV epitope specific T cells
por: Winstone, N, et al.
Publicado: (2009)

Early pro-inflammatory host response to recombinant HSV-SIV vaccination in sooty mangabeys
por: Rout, N, et al.
Publicado: (2012)

Understanding the benign nature of natural SIV infection: Implications for AIDS pathogenesis
por: Silvestri, Guido
Publicado: (2006)

P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
por: Tung, F, et al.
Publicado: (2009)

Telephone calls to boost response rates in the collection of outcome data
por: Breeman, Suzanne, et al.
Publicado: (2013)

Partial germline reversions can increase VRC07 potency and breadth
por: Rudicell, RS, et al.
Publicado: (2012)

P19-37. Replication-defective lymphocytic choriomeningitis virus vectors boost cellular and humoral immunity after DNA or adenovirus vector priming
por: Flatz, LR, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kbh77njlgi7ikmqlon18dvi5e4